ES2075860T3 - Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion. - Google Patents

Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion.

Info

Publication number
ES2075860T3
ES2075860T3 ES90115961T ES90115961T ES2075860T3 ES 2075860 T3 ES2075860 T3 ES 2075860T3 ES 90115961 T ES90115961 T ES 90115961T ES 90115961 T ES90115961 T ES 90115961T ES 2075860 T3 ES2075860 T3 ES 2075860T3
Authority
ES
Spain
Prior art keywords
salts
pirazolo
optically active
alcoxi
triazinas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90115961T
Other languages
English (en)
Inventor
Kinji Hashimoto
Masatoshi Inai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2075860T3 publication Critical patent/ES2075860T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION EXPONE UNA SAL ELEGIDA DEL GRUPO CONSISTENTE EN SALES DE METALES ALCALINOS Y ALCALINOTEREOS EN FORMA ACTIVA OPTICAMENTE A PARTIR DE UN 4-HIROXI-8(3-INFERIOR ALCOXI-4-FUEL SULFINILFENIL) PIRAZOLO [1,5-A] -1,3,5-TRIAZINA; Y UN PROCESO PARA PRODUCIR DICHOS COMPONENETES Y SUS SALES ASI COMO UNA COMPOSICION FARMACEUTICA, QUE COMPRENDE UNA CANTIDAD EFECTIVA DE LA SAL JUNTO CON UN PORTADOR NO TOXICO ACEPTABLE FARMACEUTICAMENTE
ES90115961T 1989-08-25 1990-08-21 Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion. Expired - Lifetime ES2075860T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21918189 1989-08-25
JP2179852A JP2691317B2 (ja) 1989-08-25 1990-07-06 ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法

Publications (1)

Publication Number Publication Date
ES2075860T3 true ES2075860T3 (es) 1995-10-16

Family

ID=26499580

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90115961T Expired - Lifetime ES2075860T3 (es) 1989-08-25 1990-08-21 Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion.

Country Status (10)

Country Link
US (1) US5137887A (es)
EP (1) EP0414200B1 (es)
JP (1) JP2691317B2 (es)
KR (1) KR960002851B1 (es)
CN (1) CN1028528C (es)
AU (1) AU630489B2 (es)
CA (1) CA2023430C (es)
DE (1) DE69021296T2 (es)
DK (1) DK0414200T3 (es)
ES (1) ES2075860T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006096A1 (en) * 1990-10-09 1992-04-16 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivative, production thereof, and androgen inhibitor
DE69307999T2 (de) * 1992-11-27 1997-08-14 Tsutomu Mashimo Herstellungsverfahren für einen auf Seltenerd-Eisen-Stickstoff basierter Dauermagnet
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
CA2259583C (en) * 1996-07-24 2009-11-17 Du Pont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
WO2000059908A2 (en) 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
CA2379421A1 (en) * 1999-08-27 2001-03-08 Abbott Laboratories Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
US7329658B2 (en) * 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
US7153961B2 (en) * 2003-11-25 2006-12-26 Bristol-Myers Squibb Pharma Co. Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
PT1757610E (pt) * 2004-06-14 2011-08-24 Nippon Chemiphar Co Derivado de pirimidina condensada e inibidor da xantina oxidase
EP1911760A4 (en) * 2005-07-01 2010-06-02 Nippon Chemiphar Co xanthine oxidase inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds

Also Published As

Publication number Publication date
EP0414200A2 (en) 1991-02-27
JPH03163082A (ja) 1991-07-15
KR910004623A (ko) 1991-03-29
CN1049664A (zh) 1991-03-06
CN1028528C (zh) 1995-05-24
KR960002851B1 (ko) 1996-02-27
EP0414200B1 (en) 1995-08-02
DE69021296D1 (de) 1995-09-07
JP2691317B2 (ja) 1997-12-17
CA2023430C (en) 1997-11-11
EP0414200A3 (en) 1991-11-13
DE69021296T2 (de) 1996-02-01
AU6098590A (en) 1991-02-28
AU630489B2 (en) 1992-10-29
US5137887A (en) 1992-08-11
DK0414200T3 (da) 1995-12-27
CA2023430A1 (en) 1991-02-26

Similar Documents

Publication Publication Date Title
ES2075860T3 (es) Sales de 4-hidroxi-8-(3-alcoxi c1-6-4-fenilsulfinilfenil)pirazolo(1,5-a)-1,3,5-triazinas opticamente activas y procedimiento para su produccion.
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
AR245706A1 (es) Compuestos de benzoilurea, procedimiento para su produccion, composiciones plaguicidas que los contienen e intermediarios.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
DE3163510D1 (en) Isoquinoline derivatives, processes for their preparation and pharmaceutical compositions containing them
ES2098593T3 (es) 3,4-dimetil-2,5,6-tris(p-sulfonatofenil)-1-fosfanorbornadieno; procedimiento para la fabricacion del mismo y procedimiento para la hidroformilacion de las combinaciones no saturadas de olefinas.
DE3382299D1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
NO901008D0 (no) Fremgangsmaate for fremstilling av (3-(c16-c18)alkansulfinyl- og sulfonyl-2-methoxymethyl-propyl)-(2-trimethylaminio-ethyl)-fosfater.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
AR246521A1 (es) Un procedimiento para la preparacion de derivados del cromeno.
ES2054729T3 (es) Derivados de pirrolidina.
ITMI920132A1 (it) Derivati della 8-(1-amminocicloalchil)1, 3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti
UY23103A1 (es) Composicion biocida y procedimiento para su fabricacion
ES8300722A1 (es) Procedimiento para la preparacion de carbamoiloxiamino-1,4- benzodiazepinas
NO990159L (no) FremgangsmÕte for fremstilling av enantiomerisk anrikede N-acylazetidin-2-karboksylsyrer
ES2051955T3 (es) Compuestos azaalifaticos ciclicos con funcion nitroxi, procedimiento para su produccion y medicamentos que contienen estos compuestos.
ES8504725A1 (es) Procedimiento para preparar los antipodas opticos de 8-amino-2-metil-4-fenil-1, 2, 3, 4-tetrahidroisoquinoleina
FI93725B (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
FI793889A (fi) 7,8,9,10-tetrahydrotieno/3,2-e/pyrido/4,3-b/indoler foerfarande foer framstaellning av dem och deras anvaendning som laekemedel
GT199800183A (es) Imidazotriazinonas sustituidas por 2-fenilo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414200

Country of ref document: ES